Vistagen Therapeutics (VTGN) Return on Sales (2011 - 2026)
Vistagen Therapeutics (VTGN) posted Return on Sales of 0.35% for Q1 2026, up 43.81% sequentially from 0.62% in Q4 2025, and down 943.0% YoY from 0.04% in Q1 2025.
Vistagen Therapeutics (VTGN) Return on Sales (2011 - 2026) Analysis & Trends
Vistagen Therapeutics has reported Return on Sales for 14 years, with the latest figure at 0.35% in Q1 2026.
- Quarterly Return on Sales fell 943.0% year-over-year to 0.35% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.55% (up 51.0% YoY) and the FY2026 annual result came in at 0.55%, up 51.0% from the prior year.
- Return on Sales climbed to 0.35% in Q1 2026 per VTGN's latest filing, from 0.62% in the prior quarter.
- Over five years, Return on Sales peaked at 9.08% in Q1 2025 and troughed at 4.28% in Q1 2022.
- A 5-year average of 0.2% and a median of 0.6% in 2024 frame the typical range for Return on Sales.
- The sharpest annual moves came in 2025 and 2026: Return on Sales jumped 957 bps in 2025, then sank 943 bps in 2026.
- Over 5 years, Return on Sales stood at 0.54% in 2022, then soared by 72 bps to 0.15% in 2023, then slumped by 290 bps to 0.6% in 2024, then slipped by 4 bps to 0.62% in 2025, then soared by 44 bps to 0.35% in 2026.
- According to Business Quant data, Return on Sales over the past three periods registered 0.35%, 0.62%, and 0.75% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.54 Bn | 130.69 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.89 Bn | 77.89 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.84 Bn | 59.65 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 56.53 Bn | 51.39 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.97 Bn | 36.87 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.22 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 0.00% |
| 10 | Vistagen Therapeutics | 10.49 Mn | 10.49 Mn | - | -0.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.35% |
| Dec 31, 2025 | -0.62% |
| Sep 30, 2025 | -0.75% |
| Jun 30, 2025 | -0.62% |
| Mar 31, 2025 | 9.08% |
| Dec 31, 2024 | -0.60% |
| Sep 30, 2024 | -0.71% |
| Jun 30, 2024 | -1.28% |
| Mar 31, 2024 | -0.48% |
| Dec 31, 2023 | -0.15% |
| Sep 30, 2023 | -0.22% |
| Jun 30, 2023 | -0.35% |
| Mar 31, 2023 | -0.69% |
| Dec 31, 2022 | -0.54% |
| Sep 30, 2022 | -0.20% |
| Jun 30, 2022 | -0.64% |
| Mar 31, 2022 | -4.28% |
| Dec 31, 2021 | -0.29% |
| Sep 30, 2021 | -0.36% |
| Jun 30, 2021 | -0.22% |